Maria Gonzalez

Sydney, NSW, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications

Molecular Profiling and Matched Targeted Therapy for Patients With Advanced Melanoma: Results From Part 1 of the MatchMEL Study.

Molecular Profiling and Matched Targeted Therapy for Patients With Advanced Melanoma: Results From Part 1 of the MatchMEL Study.

Journal: JCO precision oncology
Published: March 12, 2026

The Efficacy and Safety of Nutritional Supplements for Cancer Supportive Care: An Umbrella Review and Hierarchical Evidence Synthesis.

The Efficacy and Safety of Nutritional Supplements for Cancer Supportive Care: An Umbrella Review and Hierarchical Evidence Synthesis.

Journal: Integrative cancer therapies
Published: January 03, 2026

The need for another tool: Australian healthcare professionals on the use of psilocybin for existential distress in people with cancer.

The need for another tool: Australian healthcare professionals on the use of psilocybin for existential distress in people with cancer.

Journal: BMC medicine
Published: December 08, 2025

Healthcare professionals' perspectives on the barriers and enablers of cancer clinical trial participation among Arabic-speaking cancer patients in Australia: a qualitative study.

Healthcare professionals' perspectives on the barriers and enablers of cancer clinical trial participation among Arabic-speaking cancer patients in Australia: a qualitative study.

Journal: Trials
Published: November 05, 2025

Stakeholder views on integrating prehabilitation in neoadjuvant therapy for breast cancer.

Stakeholder views on integrating prehabilitation in neoadjuvant therapy for breast cancer.

Journal: European journal of oncology nursing : the official journal of European Oncology Nursing Society
Published: August 03, 2025

Neoadjuvant ipilimumab plus nivolumab in melanoma: 5-year survival and biomarker analysis from the phase 2 PRADO-trial.

Neoadjuvant ipilimumab plus nivolumab in melanoma: 5-year survival and biomarker analysis from the phase 2 PRADO-trial.

Journal: Nature medicine
Published: July 10, 2025

Online yoga for depression and anxiety symptoms in female cancer survivors: a mixed-methods feasibility study comparing group and individual delivery.

Online yoga for depression and anxiety symptoms in female cancer survivors: a mixed-methods feasibility study comparing group and individual delivery.

Journal: Complementary therapies in clinical practice
Published: June 23, 2025

FDG-PET associations with pathological response and survival with neoadjuvant immunotherapy for melanoma.

FDG-PET associations with pathological response and survival with neoadjuvant immunotherapy for melanoma.

Journal: Journal for immunotherapy of cancer
Published: March 10, 2025

Pathological response calculation assessment remains accurate with reduced tumor bed examination after neoadjuvant immunotherapy in clinically detectable stage III melanoma.

Pathological response calculation assessment remains accurate with reduced tumor bed examination after neoadjuvant immunotherapy in clinically detectable stage III melanoma.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 05, 2025

Ipilimumab plus nivolumab versus nivolumab alone in patients with melanoma brain metastases (ABC): 7-year follow-up of a multicentre, open-label, randomised, phase 2 study.

Ipilimumab plus nivolumab versus nivolumab alone in patients with melanoma brain metastases (ABC): 7-year follow-up of a multicentre, open-label, randomised, phase 2 study.

Journal: The Lancet. Oncology
Published: September 26, 2024

Impact of personalized response-directed surgery and adjuvant therapy on survival after neoadjuvant immunotherapy in stage III melanoma: Comparison of 3-year data from PRADO and OpACIN-neo.

Impact of personalized response-directed surgery and adjuvant therapy on survival after neoadjuvant immunotherapy in stage III melanoma: Comparison of 3-year data from PRADO and OpACIN-neo.

Journal: European journal of cancer (Oxford, England : 1990)
Published: September 10, 2024

Neoadjuvant triplet immune checkpoint blockade in newly diagnosed glioblastoma.

Neoadjuvant triplet immune checkpoint blockade in newly diagnosed glioblastoma.

Journal: Nature medicine
Published: July 24, 2024
Showing 1-12 of 36

Last Updated: 09/26/2026